MX2009005048A - Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona. - Google Patents

Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona.

Info

Publication number
MX2009005048A
MX2009005048A MX2009005048A MX2009005048A MX2009005048A MX 2009005048 A MX2009005048 A MX 2009005048A MX 2009005048 A MX2009005048 A MX 2009005048A MX 2009005048 A MX2009005048 A MX 2009005048A MX 2009005048 A MX2009005048 A MX 2009005048A
Authority
MX
Mexico
Prior art keywords
thiazolidin
derivatives
preparation
imino
new process
Prior art date
Application number
MX2009005048A
Other languages
English (en)
Spanish (es)
Inventor
Martin Bolli
Stefan Abele
Gunther Schmidt
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MX2009005048A publication Critical patent/MX2009005048A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2009005048A 2006-11-23 2007-11-22 Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona. MX2009005048A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006054409 2006-11-23
PCT/IB2007/054752 WO2008062376A2 (en) 2006-11-23 2007-11-22 New process for the preparation of 2-imino-thiazolidin-4-one derivatives

Publications (1)

Publication Number Publication Date
MX2009005048A true MX2009005048A (es) 2009-05-25

Family

ID=39316391

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005048A MX2009005048A (es) 2006-11-23 2007-11-22 Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona.

Country Status (13)

Country Link
US (1) US8263780B2 (enExample)
EP (2) EP2489662B1 (enExample)
JP (1) JP4669564B2 (enExample)
KR (1) KR101255879B1 (enExample)
CN (2) CN101541772B (enExample)
AU (1) AU2007323042B2 (enExample)
CA (1) CA2669069C (enExample)
DK (2) DK2489662T3 (enExample)
ES (2) ES2410793T3 (enExample)
IL (1) IL198847A (enExample)
MX (1) MX2009005048A (enExample)
TW (1) TWI460166B (enExample)
WO (1) WO2008062376A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
US7435828B2 (en) 2003-11-21 2008-10-14 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
HRP20170246T4 (hr) 2008-03-17 2020-02-07 Actelion Pharmaceuticals Ltd. Režim doziranja za selektivni agonist s1p1-receptora
GB0819182D0 (en) * 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms
EP2885266B1 (en) 2012-08-17 2020-03-18 Actelion Pharmaceuticals Ltd Process for the preparation of (2z,5z)-5-(3-chloro-4-((r)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimino)-3-(o-tolyl)thiazolidin-4-one and intermediate used in said process
KR102590068B1 (ko) 2014-12-11 2023-10-16 액테리온 파마슈티칼 리미티드 선택적 s1p1 수용체 효능제에 대한 투약 섭생
MA41139A (fr) 2014-12-11 2017-10-17 Actelion Pharmaceuticals Ltd Combinaison pharmaceutique comportant un agoniste sélectif du récepteur sip1
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
WO2019060147A1 (en) * 2017-09-19 2019-03-28 Teva Pharmaceuticals Usa, Inc. NEW CRYSTALLINE POLYMORPHE FROM PONESIMOD
US11014940B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Thiazolidinone and oxazolidinone compounds and formulations
US11186556B1 (en) 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
US11013723B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms of a thiazolidinone compound, compositions and methods of use thereof
US11014897B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
US20220315545A1 (en) * 2019-07-10 2022-10-06 Bayer Aktiengesellschaft Process of preparing 2-(phenylimino)-1,3-thiazolidin-4-ones
EP3997076A1 (de) * 2019-07-10 2022-05-18 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-1,3-thiazolidin-4-onen
MX2022005014A (es) 2019-10-31 2022-05-16 Idorsia Pharmaceuticals Ltd Combinacion de un antagonista de cxcr7 con un modulador del receptor s1p1.
KR20200019639A (ko) 2020-01-30 2020-02-24 전대연 만남의 스마트 도착시스템
BR112022014704A2 (pt) * 2020-02-18 2022-10-11 Bayer Ag Processo para a preparação de 2-(fenilimino)-3-alquil-1,3-tiazolidin-4-onas
US20240368094A1 (en) 2021-08-17 2024-11-07 Teva Czech Industries S.R.O Polymorphs of ponesimod
EP4212156A1 (en) 2022-01-13 2023-07-19 Abivax Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator
WO2023152691A1 (en) * 2022-02-10 2023-08-17 Metrochem Api Pvt Ltd Process for the preparation of ponesimod and its intermediates thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077402A (en) * 1954-12-06 1963-02-12 Polaroid Corp Photographic color processes, products, and compositions
NL270002A (enExample) 1960-10-08
OA03835A (fr) 1970-07-17 1971-12-24 Rhone Poulenc Sa Nouveaux dérivés de la thiazolidine, leur préparation et les compositions qui les contiennent.
US5362733A (en) 1990-04-27 1994-11-08 Orion-Yhtyma Oy Pharmacologically active catechol derivatives
TW221689B (enExample) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
ATE212018T1 (de) * 1993-02-26 2002-02-15 Otsuka Pharma Co Ltd Thiazole oder imidazole derivate als maillard reaktion inhibitoren
KR960022486A (ko) 1994-12-29 1996-07-18 김준웅 신규 티아졸리딘-4-온 유도체
US6353006B1 (en) * 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
WO2001019807A1 (en) 1999-09-14 2001-03-22 Shionogi & Co., Ltd. 2-imino-1,3-thiazine derivatives
KR100608416B1 (ko) * 1999-11-12 2006-08-02 후지모토 쿄다이 가부시키가이샤 2-(ｎ-시아노이미노)티아졸리딘-4-온 유도체
US20050019825A9 (en) * 2002-03-15 2005-01-27 Qing Dong Common ligand mimics: pseudothiohydantoins
CA2493843C (en) 2002-07-10 2012-04-17 Applied Research Systems Ars Holding N.V. Azolidinone-vinyl fused-benzene derivatives
GB0217152D0 (en) 2002-07-24 2002-09-04 Novartis Ag Organic compounds
UA80572C2 (en) * 2002-11-22 2007-10-10 Smithkline Beecham Corp THIAZOLIDINE DERIVATIVES AS hYAK3 INHIBITORS
US20040167192A1 (en) * 2003-01-16 2004-08-26 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
US7435828B2 (en) * 2003-11-21 2008-10-14 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
WO2005082901A1 (en) * 2004-02-25 2005-09-09 Smithkline Beecham Corporation Novel chemical compounds
WO2006094233A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. N,n'-dicyclic isothiourea sirtuin modulators
HRP20170246T4 (hr) * 2008-03-17 2020-02-07 Actelion Pharmaceuticals Ltd. Režim doziranja za selektivni agonist s1p1-receptora
GB0819182D0 (en) * 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms

Also Published As

Publication number Publication date
JP2010510976A (ja) 2010-04-08
WO2008062376A3 (en) 2008-07-10
BRPI0718986A2 (pt) 2014-02-11
CA2669069C (en) 2015-02-17
DK2094676T3 (da) 2013-06-10
TWI460166B (zh) 2014-11-11
EP2094676B1 (en) 2013-04-10
KR101255879B1 (ko) 2013-04-17
AU2007323042A1 (en) 2008-05-29
ES2523401T3 (es) 2014-11-25
TW200831474A (en) 2008-08-01
KR20090081009A (ko) 2009-07-27
US20110201821A2 (en) 2011-08-18
IL198847A (en) 2015-07-30
EP2094676A2 (en) 2009-09-02
US20100317867A1 (en) 2010-12-16
CN101541772A (zh) 2009-09-23
EP2489662B1 (en) 2014-08-06
EP2489662A1 (en) 2012-08-22
DK2489662T3 (da) 2014-10-20
WO2008062376A2 (en) 2008-05-29
US8263780B2 (en) 2012-09-11
CA2669069A1 (en) 2008-05-29
ES2410793T3 (es) 2013-07-03
IL198847A0 (en) 2010-02-17
CN103087004A (zh) 2013-05-08
AU2007323042B2 (en) 2012-12-20
JP4669564B2 (ja) 2011-04-13
CN101541772B (zh) 2013-04-17

Similar Documents

Publication Publication Date Title
MX2009005048A (es) Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona.
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
WO2007140385A3 (en) Thiazole compounds as cannabinoid receptor ligands and uses thereof
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
TW200745084A (en) Novel compounds
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
WO2009046842A3 (de) Thialzolderivate zur behandlung von krebs
TW200745004A (en) Novel compounds, their preparation and use
MX2010008713A (es) Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii.
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
UA97369C2 (ru) Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе
WO2007030361A3 (en) Benzimidazole thiophene compounds as plk inhibitors
WO2011047055A8 (en) Novel mek inhibitors, useful in the treatment of diseases
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
SG158091A1 (en) Imidazoazepinone compounds
JO2749B1 (en) Indole-2-Wen derivatives bilaterally substituted at position 3, their preparation and therapeutic application
ZA200801875B (en) Isoquinolines as IGF-IR inhibitors
TW200639156A (en) New compounds
PL1758852T3 (pl) Podstawione związki cyklopentenu
TW200745122A (en) New compounds I
WO2008019030A8 (en) Modified azole compounds as antiinfective agents
TW200800993A (en) Organic compounds

Legal Events

Date Code Title Description
FG Grant or registration